EUVIMEDEUVIMED entdecken
Crossref

Spatial expression of GINS3 in gastric cancer cell subpopulations and identification of its downstream functional genes

Lizhi Chen, Jialing Xiao, Xueqin Qiu, Linyu Yang, Yi Deng

Translational Gastroenterology and Hepatology · 2023-01 · 0-0

DOI: 10.21037/tgh-2026-0168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2023-01. Verfasst von Lizhi Chen und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) exhibits substantial molecular and cellular heterogeneity, which complicates the identification of biomarkers and therapeutic targets. GINS3, a component of the DNA replication machinery, has been implicated in several cancers, but its role in GC remains unclear. This study aimed to characterize GINS3 expression, its prognostic associations, and its distribution across cellular subpopulations in GC, and to examine the effects of GINS3 silencing in vitro.

Methods

We used The Cancer Genome Atlas (TCGA) data to examine GINS3 expression in GC and its association with overall survival. We analyzed single-cell RNA sequencing data from GSE183904 to compare GINS3 expression across cell populations. After silencing GINS3 with siRNA in SGC-7901 and BGC-823 cells, we profiled transcriptional changes by RNA sequencing in SGC-7901 cells and measured candidate gene expression by quantitative real-time polymerase chain reaction (qPCR) in both cell lines. We also measured cell-cycle distribution, 5-ethynyl-2'-deoxyuridine (EdU) incorporation, colony formation, wound closure, and Transwell staining.

Results

GINS3 expression was higher in GC tissues than in normal tissues and positively correlated with tumor mutational burden (R=0.47). Higher expression was associated with lower mortality in multivariable Cox analysis [hazard ratio (HR)=0.596, 95% confidence interval (CI): 0.391–0.907], although Kaplan-Meier analysis showed no significant survival difference (P=0.24). Exploratory cell-level analysis showed higher GINS3 expression in stage IV tumor epithelial cells than in normal controls, accompanied by differences in immune-response and signaling pathways. GINS3 knockdown altered transcriptomic profiles and reduced BCAT2, SDC4, and ZC3H15 expression in both cell lines. Silencing increased the S-phase population with continued DNA synthesis and reduced estimated colony counts in SGC-7901 cells (P=0.03). Transwell staining decreased, but wound closure did not differ significantly.

Conclusions

GINS3 expression is elevated in GC tissues. In vitro, GINS3 silencing increases the S-phase cell population, reduces clonogenic growth in SGC-7901 cells, and decreases BCAT2, SDC4, and ZC3H15 expression in SGC-7901 and BGC-823 cells.

Zitieren

APA

Chen, L., Xiao, J., Qiu, X., Yang, L., & Deng, Y. (2023). Spatial expression of GINS3 in gastric cancer cell subpopulations and identification of its downstream functional genes. Translational Gastroenterology and Hepatology, 0, 0-0. https://doi.org/10.21037/tgh-2026-0168

Vancouver

Chen L, Xiao J, Qiu X, Yang L, Deng Y. Spatial expression of GINS3 in gastric cancer cell subpopulations and identification of its downstream functional genes. Translational Gastroenterology and Hepatology. 2023;0:0-0. doi:10.21037/tgh-2026-0168

BibTeX
@article{Chen2023,
  author = {Chen, Lizhi and Xiao, Jialing and Qiu, Xueqin and Yang, Linyu and Deng, Yi},
  title = {Spatial expression of GINS3 in gastric cancer cell subpopulations and identification of its downstream functional genes},
  journal = {Translational Gastroenterology and Hepatology},
  year = {2023},
  volume = {0},
  pages = {0--0},
  doi = {10.21037/tgh-2026-0168}
}
Kostenlos starten →